Quest Diagnostics Inc (NYSE:DGX)
$ 143.33 -0.84 (-0.58%) Market Cap: 15.92 Bil Enterprise Value: 20.89 Bil PE Ratio: 19.29 PB Ratio: 2.47 GF Score: 82/100

Quest Diagnostics Inc at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 03:40PM GMT
Release Date Price: $105.01 (+0.77%)
Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

So I can still say good morning because it's 11:40. So this is the last a.m. session for first day of Morgan Stanley Global Healthcare Conference. I'm Ricky Goldwasser, Morgan Stanley's health care services analyst. And for all holding disclosures, both personal and Morgan Stanley, please go to the Morgan Stanley website.

And with that, I'm very pleased to introduce our next guest speakers here, Quest Diagnostics' executive team. To my left is Steve Rusckowski, Quest's CEO; and Shawn Bevec, Quest's Head of IR.

So Steve, Shawn, welcome to the Morgan Stanley conference.

Stephen H. Rusckowski
Quest Diagnostics Incorporated - Chairman, President & CEO

Thank you. Thank you, Ricky. Thanks for having us.

Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

Thank you for being here with us.

Questions & Answers

Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot